Clinical application of FDG-PET/CT in metastatic infections.

Authors :: Kouijzer IJ
Vos FJ
Bleeker-Rovers CP
Oyen WJ
Source :: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2017 Jun; Vol. 61 (2), pp. 232-246. Date of Electronic Publication: 2016 Feb 16.
Publication Year :: 2017
Abstract: FDG-PET/CT has proven its clinical value and cost-effectiveness in diagnosing metastatic infections in patients with Gram-positive bacteremia. In identification of metastatic foci, FDG-PET/CT is useful as a screening method when localizing symptoms are absent because it provides whole-body coverage. FDG-PET/CT detects early metabolic activity rather than the late anatomical changes as visualized by computed tomography and magnetic resonance imaging. FDG-PET/CT allows more precise localization of infection within a shorter time span between injection and diagnosis as compared to conventional nuclear imaging. This review focuses on the clinical application of imaging of metastatic infectious diseases, with an emphasis on FDG-PET/CT putting it in perspective with other imaging modalities.

Subjects :: Fluorodeoxyglucose F18
Humans
Whole Body Imaging
Gram-Positive Bacterial Infections diagnostic imaging
Positron Emission Tomography Computed Tomography

Language :: English
ISSN :: 1827-1936
Volume :: 61
Issue :: 2
Database :: MEDLINE
Journal :: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..
Publication Type :: Academic Journal
Accession number :: 26883515
Full Text :: https://doi.org/10.23736/S1824-4785.16.02735-7